Tucson VA Medical Center Selects Omnicell’s Central Pharmacy Dispensing Service to Enhance Medication Inventory Management

[ad_1]

First Veterans Affairs facility to implement automation and technology-enabled services to support more cost-effective workflows and improve pharmacy operations

MOUNTAIN VIEW, Calif., Nov. 2, 2021 – (BUSINESS WIRE) – Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leading provider of drug management solutions and adherence tools for the Health Systems and Pharmacies, announced today that Tucson VA Medical Center has selected the Company’s Central Pharmacy Dispensing Service (“CPDS”) to improve patient safety, improve operational efficiency, and manage inventory for its central pharmacies to optimize.

The Veterans Health Administration is America’s largest integrated health system, serving 9 million enrolled veterans each year.

Arizona-based Tucson VA Medical Center will add the company’s CPDS to its Omnicell platform, which includes XR2 pharmacy dispensing technology, operations staff, maintenance support, and embedded intelligence for real-time insights. Tucson VA Medical Center will be the first in the Veterans Administration to implement this comprehensive “as-a-service” model designed to help improve pharmacy operations, increase patient safety, reduce drug waste, and reallocate high-quality clinics Resource from frustrating manual tasks to direct patient care.

Omnicell is committed to transforming the pharmacy supply model by supporting the industry vision of the Autonomous Pharmacy that will make medication management processes more automated as interoperable systems turn data into actionable advice and enable improvements that increase safety, efficiency and human potential at the same time support compliance and business results.

Omnicell’s CPDS supports this vision by automating critical workflows so pharmacy staff can focus on patients rather than administrative tasks. CPDS is the cornerstone of Omnicell’s automation platform.

The story goes on

“We are honored and excited to offer innovative products and services that support our nation’s veterans and their families,” said Scott Seidelmann, Omnicell’s executive vice president and chief commercial officer. “We believe this expanded technology partnership with Tucson VA Medical Center will help them reduce dispensing errors, replace manual processes and get pharmacists to practice at the top of their license.”

About Omnicell

Since 1992, Omnicell has been committed to transforming the pharmacy supply model to dramatically improve outcomes and reduce costs. With the vision of the autonomous pharmacy, a combination of automation, intelligence and technology-based services, supported by a cloud data platform, Omnicell supports more efficient ways of managing drugs in all care areas. Over 7,000 facilities worldwide use Omnicell automation and analytics solutions to improve operational efficiencies, reduce medication errors, provide actionable information, and improve patient safety. More than 60,000 institutional and retail pharmacies in North America and the UK use Omnicell’s innovative drug compliance and population health solutions to improve patient engagement and compliance and reduce costly hospital readmissions. To learn more, visit www.omnicell.com.

OMNICELL is a registered trademark and the Omnicell logo is a trademark of Omnicell, Inc.

Forward-Looking Statements

Certain statements in this press release address future plans and goals for Omnicell’s products and services. These statements are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results and other events could differ materially from those anticipated in forward-looking statements due to numerous factors that involve significant known and unknown risks. These risks and uncertainties include, but are not limited to, those detailed in the Risk Factors section of Omnicell’s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, as well as in the Company’s other reports filed with the US Securities and Exchange Commission, available at www.sec.gov. Forward-looking statements should be considered in light of these risks and uncertainties. Investors and others are cautioned not to place undue reliance on forward-looking statements. All forward-looking statements contained in this press release speak only as of the date of this press release. Omnicell assumes no obligation to update such statements as a result of changes in circumstances, new information, future events, or for any other reason, except as required by law.

OMCL-G

View source version on businesswire.com: https://www.businesswire.com/news/home/20211102005507/en/

contacts

Betsy Martinelli
Omnicell, Inc.
724-741-8341
betsy.martinelli@omnicell.com

[ad_2]